High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

The following is a summary of “ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome,” published in the April 2025 issue of ...

Having been first diagnosed with a rare form of cancer called mycosis fungoides at the age of 28 he eventually died of the illness at the age of 68 in 1995. He and Patricia, his wife of 43 years ...

Tumor necrosis factor (TNF) receptor type II (TNFR2) is expressed in various tumor cells and some immune cells, such as regulatory T cells and myeloid-derived suppressing cells. TNFR2 contributes a ...